Interdigitating dendritic cell tumors in two patients exposed to topical calcineurin inhibitors.
Gordon
Melinda K
MK
Kraus
Madeleine
M
van Besien
Koen
K
D000287:Administration, Topical; D000368:Aged; D065095:Calcineurin Inhibitors; D003713:Dendritic Cells / Q000187:drug effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008198:Lymph Nodes / Q000473:pathology; D008214:Lymphocytes / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012509:Sarcoma / Q000139:chemically induced*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus